mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
Prif Awduron: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Nature Portfolio
2022-08-01
|
Cyfres: | npj Vaccines |
Mynediad Ar-lein: | https://doi.org/10.1038/s41541-022-00511-y |
Eitemau Tebyg
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
gan: Susanne Rauch, et al.
Cyhoeddwyd: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
gan: Nicole Roth, et al.
Cyhoeddwyd: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
gan: Charlie Fricke, et al.
Cyhoeddwyd: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
gan: Nicole Roth, et al.
Cyhoeddwyd: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
gan: Björn Corleis, et al.
Cyhoeddwyd: (2023-02-01)